维持性血液透析患者中心静脉狭窄的发病率、通路结局与生存分析
该研究在同一中心2006至2013年起始透析的2811例患者中回顾性分析中心静脉狭窄,发现120例(4.3%)发生中心静脉狭窄,中位透析龄2.9年;与匹配对照相比生存无差异(中位5.1年 vs 5.2年,P=0.54)。在500例有导管使用史患者中,34例(6.8%)发生中心静脉狭窄,发生率2.2/100患者年;既往导管数量多和起搏器植入是独立危险因素,年龄较大者风险较低。
要点
- 中心静脉狭窄发生率4.3%,中位透析龄2.9年,但未影响患者生存。
- 既往导管数量越多、起搏器植入者中心静脉狭窄风险显著升高。
- 年龄较大者中心静脉狭窄风险较低,支持该人群选择性使用隧道导管。
核心结论
- 中心静脉狭窄发生在少数血液透析患者中,与未来通路受损相关,但不影响生存。
- 在有导管使用史的患者中,中心静脉狭窄风险与导管数量和总导管时长相关,非透析因素如起搏器也重要。
- 老年患者中心静脉狭窄风险较低,支持在该组选择性使用隧道导管。
研究设计与样本
- 在同一人群队列中开展两项研究,纳入2006年1月至2013年12月单中心所有起始血液透析患者。
- 第一项研究回顾性分析中心静脉狭窄的存在,描述通路结局并与来自同一人群的匹配对照比较生存。
- 第二项研究分析该队列中有导管使用史的患者亚组,确定中心静脉狭窄的危险因素。
主要发现
- 2811例患者中120例(4.3%)诊断中心静脉狭窄,中位透析龄2.9年(四分位距1.8-4.6年)。
- 与匹配对照相比,中心静脉狭窄患者生存相似(中位5.1年 vs 5.2年;P=0.54)。
- 500例有导管使用史的患者中34例(6.8%)发生中心静脉狭窄,发生率为2.2/100患者年。
- 既往导管数量多(相对风险2.2;95%CI 1.6-2.9)和起搏器植入(相对风险3.9;95%CI 1.7-8.9)与中心静脉狭窄发生率较高相关。
- 年龄较大与中心静脉狭窄发生率较低相关(每十年相对风险0.7;95%CI 0.6-0.8)。
临床怎么用
- 对既往导管数量多或植入起搏器的血液透析患者,应警惕中心静脉狭窄并关注通路功能。
- 老年患者中心静脉狭窄风险较低,可考虑选择性使用隧道导管。
局限性
- 研究为单中心回顾性分析,部分分析基于有导管使用史的亚组。
- 中心静脉狭窄的诊断依赖回顾性分析,可能存在 ascertainment 偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Central venous catheters have traditionally provided access for urgent hemodialysis, but are also sometimes advocated as an option for older or more comorbid patients. Adverse effects of this type of dialysis access include central venous stenosis, for which the risk factors and consequences are incompletely understood. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted two studies within the same population cohort, comprising all patients starting hemodialysis in a single center from January 2006 to December 2013. First, patients were retrospectively analyzed for the presence of central venous stenosis; their access outcomes are described and survival compared with matched controls drawn from the same population. Second, a subset of patients with a history of catheter access within this cohort was analyzed to determine risk factors for central venous stenosis. RESULTS: Among 2811 patients, central venous stenosis was diagnosed in 120 (4.3%), at a median dialysis vintage of 2.9 (interquartile range, 1.8-4.6) years. Compared with matched controls, patients with central venous stenosis had similar survival (median 5.1 versus 5.2 years; P=0.54). Among a subset of 500 patients, all with a history of catheter use, 34 (6.8%) developed central venous stenosis, at a rate of 2.2 per 100 patient-years. The incidence of central venous stenosis was higher with larger number of previous catheters (relative risk [RR], 2.2; 95% confidence interval [95% CI]. 1.6 to 2.9), pacemaker insertion (RR, 3.9; 95% CI, 1.7 to 8.9), and was lower with older age (RR, 0.7 per decade; 95% CI, 0.6 to 0.8). In a Cox proportional hazards model, the catheter number, pacemaker, and younger age at dialysis initiation were all significant independent risk factors for central venous stenosis. CONCLUSIONS: Central venous stenosis occurred in a minority of patients on hemodialysis, and was associated with compromised future access, but unchanged survival. Among patients with a history of catheter use, risk related to both the number of catheters and the total catheter duration, although nondialysis factors such as pacemakers were also important. Central venous stenosis risk was lower in older patients, supporting the selective use of tunneled catheters in this group.
引用
- Adwaney A, Lim C, Blakey S, et al. Central Venous Stenosis, Access Outcome and Survival in Patients undergoing Maintenance Hemodialysis. Clin J Am Soc Nephrol. 2019. PMID: 30765534. doi:10.2215/CJN.07010618
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。